Introduction
Cancer is one of the most threatening diseases for human beings. The detection of tumor biomarkers plays an important role in evaluation of recovery for patients and in clinical diagnosis of cancer. 1, 2 The dominant quantitative detection of tumor markers in a clinic are attributed to the immunoassay methods, due to the high selectivity of specific molecular recognition between antigen and antibody. Numerous methods for the determination of a single tumor marker have been well summarized. 3, 4 However, most cancers have more than one marker associated with their incidence. Therefore, the measurement of a single tumor marker is not sufficient to diagnose cancer. Thus, simultaneous detection of several tumor markers has been attracted much attention to improve the diagnostic accuracy. Multiplexed immunoassay can offer higher sample throughput, less sample consumption, shorter assay time and lower cost than the traditional parallel single analyte immunoassay. [5] [6] [7] Some electrochemical 8, 9 and optical arrays 7,10-13 have been proposed for multiplexed detection of tumor markers. Ju et al. summarized the general development of multiplexed immunoassays in detail. 3, 14 Alpha-fetoprotein (AFP), an oncofetal glycoprotein with a molecular weight of approximately 70000 Da, is a marker related to hepatocellular cancer. The average concentration of AFP is about 25 ng mL -1 in healthy human serum, but rises greatly in patients with liver cancer. 15, 16 It is an important tumor marker in the diagnosis and management of original liver carcinoma.
Carcinoembryonic antigen (CEA), with the characteristic of human embryo antigen, is an acidic glycoprotein with a molecular weight of about 200 kDa. The concentration of serum CEA is related to colon cancer, 17 lung cancer, 18 ovarian carcinoma, 19 breast cancer 20 and cystadenocarcinoma. 21 Because the CEA level in serum is also related to the state of a tumor, it can be directly used for evaluating the curative effect and for judging recrudescence or metastasis as a marker. 22 By using polyethersulfone membrane as the immobilization matrix of antigens, a duplex-channel immunosensing system has been proposed for the simultenous detection of AFP and CEA based on flow injection chemiluminescent (CL) analysis. 23 In our previous work, two movable flow cells in series were used to detect AFP and CEA simultaneously based on flow injection CL analysis. 24 Yang et al. adopted an automated support-resolution strategy to construct a one-way CL multiplex immunoassay for the determination of CEA and AFP. 25 In order to improve the detection sensitivity, the current work was focused on the signal amplification by using increased amounts of horseradish peroxidase (HRP). By immobilizing HRP-labeled secondary antibody on the surface of gold nanoparticles (AuNPs), researchers could prepare an amplification label for highly sensitive detection of protein based on a sandwich immunoassay. 26, 27 The enhanced signals were attributed to a high HRP-tag molar ratio on AuNPs. Herein, HRP-labeled antibody of CEA and AFP were co-coated with pure HRP enzyme on the surface of AuNPs to prepare the signal-amplified immunological probe (HRP/CEA-Ab2/Au and HRP/AFP-Ab2/Au).
Mesoporous silica with high ratio surface areas and pore volumes has been considered as a promising matrix for the immobilization of proteins. 28 Due to the simple process of protein immobilization and separation by magnetic separation, magnetic mesoporous silica (Fe3O4/SiO2) combined the advantages of mesoporous silica and magnetic particles.
A sensitive dual immunoassay was proposed for the determination of carcinoembryonic antigen (CEA) and α-fetoprotein (AFP) based on signal amplification. Monoclonal antibodies immobilized on magnetic mesoporous silica particles (Fe3O4/SiO2) were prepared as the primary probe. Horseradish peroxidase (HRP) labeled antibodies co-coated with HRP on gold nanoparticles (AuNPs) were used as the secondary probe to achieve signal amplification. HRP tags were retained in the flow cells after a sandwich immunoassay. By controlling two switches on the two channels, chemiluminescent substrates were injected orderly man way, and then signals for CEA and AFP were sequentially detected by HRP-luminol-H2O2. Due to the increased amount of HRP on AuNPs and the increased amount of monoclonal antibodies on Fe3O4/SiO2, the signals were largely amplified. Under the optimal conditions, CEA and AFP could be Recently, Fe3O4/SiO2 has been widely used as a special protein immobilizing carrier for the construction of the immunosensor. 29 In the current work, Fe3O4/SiO2 particles were synthesized as the immobilization matrix of the monoclonal antibodies (Ab1) of CEA and AFP to prepare the primary probe (CEA-Ab1/Fe3O4/SiO2 and AFP-Ab1/Fe3O4/SiO2). Two subminiature quartz flow cells were set upon the photo multiplier tube (PMT) in parallel.
After a sandwich immunoassay, the CL signals from CEA and AFP were near simultaneously collected by flow injection CL analysis. Due to the increased amounts of CEA-Ab1 and AFP-Ab1 on Fe3O4/SiO2 particles and the increased amount of HRP tags on AuNPs, the CL signal was dual amplified. By controlling two switches on the two channels, the proposed method was in favor of reducing sample consumption and facilitating the operation. It may provide a promising platform for a simple multiplexed determination in the clinic immunoassay.
Experimental

Materials and reagents
CEA and AFP ELISA kits were purchased from Henan Bosai Bio-tech Co. (China). They consisted of a series of CEA and AFP standard solutions with concentrations from 0 to 80 ng mL -1 and 0 to 200 ng mL -1 , and the stock solutions of CEA and AFP monoclonal antibodies, respectively. HRP (RZ > 3.0, A > 250 U mg -1 ) was purchased from Shanghai Xueman Biotechnology Ltd. Comp. (China). The silane reagents of the tetraethyl orthosilicate (TEOS) and aminopropyltriethoxyl silane (APTS) were purchased from Sigma-Aldrich Chemical Co. EO20PO70EO20 (P123), bovine serum albumin (BSA), 1-ethyl-3-(3-dimethyl aminopropyl)-carbodiimide (EDC) and N-hydroxysuccinimide (NHS) were obtained from ACROS. Trimethylbenzene (TMB) and ferric chloride were purchased from Shanghai Chemical Reagent Comp. (China). Other chemicals were of analytical grade and used without further purification. All solutions were prepared with doubly-distilled water. The solution of EDC/NHS was prepared by mixing 5 mM EDC and 8 mM NHS at a volume ratio of 1:1 in prior to use; 0.01 mol L -1 pH 7.4 phosphate buffer solution (PBS) was used as coupling buffer for antibody immobilization; 0.01 mol L -1 pH 9.0 PBS was used as wash buffer; 0.01 mol/L luminol stock solution was prepared by dissolving 0.1772 g luminol in 0.1 mol L -1 pH 11.0 NaOH-NaHCO3 buffer solution and kept in dark, then diluted by 0.1 mol L -1 pH 9.0 Tris-HCl buffer solution prior to use. Doubly distilled water was used throughout the experiment.
Apparatus
The CL detection was conducted on a flow injection CL system (IFFM-E Luminescence Analyzer, Xi'an Remax Electronic Instrument Ltd. Co., China). The CL emission was Step No.
Step 
Preparation of Fe3O4/SiO2 and monoclonal antibody modified Fe3O4/SiO2
The synthesis of mesoporous silica was according to the reported method. 30 The surface area and average pore size of mesoporous silica obtained by the N2 adsorption isotherms and calculated by the BET method were 826 cm 2 g -1 and 15 nm. Super paramagnetic Fe3O4 nanoparticles were prepared by co-precipitating Fe 2+ and Fe 3+ ions with ammonia solution, 31 and the diameter of particles was approximately 10 nm by TEM. The mixture of mesoporous silica and Fe3O4 (mass ratio 5:2) was stirred for 4 h at room temperature, then transferred to a Teflon bottle and heated at 100 C for 2 days. Fe3O4/SiO2 was obtained after a washing and separation step; 0.2541 g Fe3O4/SiO2 was mixed with 0.5 mL APTS to prepare amino functionalized Fe3O4/SiO2 nanoparticles. A 250-μL monoclonal antibody of CEA (100 ng mL -1 ) was mixed with amino functionalized Fe3O4/SiO2 (0.05 g) and 1 mL EDC/NHS solution, and stirring was continued for 30 min at room temperature. Then, the prepared CEA-Ab1/Fe3O4/SiO2 was dipped in a BSA solution (0.5%) to block the active sites. AFP-Ab1/Fe3O4/SiO2 was also prepared according to the above method. The prepared CEA-Ab1/Fe3O4/SiO2 and AFP-Ab1/Fe3O4/SiO2 were re-suspended in 0.01 M PBS and kept at 4 C in prior to use.
Preparation of signal-amplified immunological probes
AuNPs were prepared according to our previous work, 32 and the diameter was approximately 9 nm by TEM. HRP-labeled CEA antibodies were added dropwise to an AuNPs suspension (1 mL) at pH 9.0 and incubated for 30 min at room temperature. Then, the conjugate was centrifuged at 8000 rpm for 30 min, and re-suspended in 0.5% HRP solution to block the active sites. After washing by distilled water, the CL signal-amplified immunological probe of HRP/CEA-Ab2/Au was obtained. The amplified CL immunological probe of HRP/AFP-Ab2/Au was also prepared according to the above method. All of the prepared probes were dispersed in 1 mL 0.01 M PBS and stored at 4 C in prior to use.
Dual immunoassay for CEA and AFP
A detailed procedure of the sequential determination of CEA and AFP is given in Fig. 1 and Table 1 . Two subminiature quartz flow cells were set upon the PMT in parallel. As soon as CEA-Ab1/Fe3O7/SiO2 and AFP-Ab1/Fe3O4/SiO2 were injected into the corresponding flow cell, they were adsorbed on the inside walls by the bar magnet. Then, the mixed solutions of CEA, AFP, HRP/CEA-Ab2/Au and HRP/AFP-Ab2/Au were injected into the two flow cells and stopped for 30 min. Based on a sandwich immunoassay format, the HRP tags were retained in the flow cells. Finally, the CL substrates of luminol and H2O2 were controlled to the two parallel flow cells orderly man way, so the sequential determination of two tumor markers was achieved. 
Results and Discussion
Optimization of immunoassay conditions
The effects on the dual immunoassay, such as the concentrations of luminol and H2O2, the incubation time, and the pH value of the buffer solution, were investigated in the current work. We examined the effects of the concentrations of luminol and H2O2 on the CL signals. As shown in Figs. 2a and  2b , the CL intensity reached the maximum value at the luminol and H2O2 concentrations of 0.5 and 10 mM when the concentrations of H2O2 and luminol were set at 10 and 0.5 mM, respectively. The CL emission in the Tris-HCl buffer was more stable than in other buffers such as PBS, Na2CO3-NaHCO3. The optimal pH value of the buffer solution was investigated and the result is shown in Fig. 2c . The CL signals increased with the increasing pH value and reached the maximum intensity at pH 9.0. Thus, the optimizing pH value was chose as 9.0. The incubation time for the sandwich immunological reaction was selected, and the result is shown in Fig. 2d . The CL signals increased with the increasing incubation time and then tended to equilibrium at 40 min. In order to reduce the detection time, the optimal incubation time was chosen as 30 min in this work. When the incubation time was selected as 30 min, the CL signals for CEA reached 94% of its maximum value, and the CL signals of AFP reached 92% of the maximum value.
Sequential determination of AFP and CEA
In the current work, two subminiature quartz flow cells were constructed in parallel and set upon the PMT. The CEA-Ab1/Fe3O4/SiO2 and AFP-Ab1/Fe3O4/SiO2 were adsorbed on the corresponding inside wall by magnet bar. After introduced the mixture of CEA, AFP, HRP/CEA-Ab2/Au and HRP/AFP-Ab2/Au with a washing step, the sandwich immuno-conjugates were formed and the HRP tags were retained in the flow cell. The CL signals for CEA and AFP were near simultaneously collected, and then the simultaneous determination of two tumor markers was achieved.
Under the optimum detection conditions, typical flow injection CL signals obtained with the sandwich multiplexed immunoassay for CEA and AFP are shown in Fig. 3 . CEA and AFP could be sequentially assayed in the linear ranges of 1.0 -80 and 1.0 -75 ng mL -1 with detection limits of 0.25 and 0.5 ng mL -1 , respectively. The regression equations were I = 72.9 + 29. 
Evaluation of cross-reactivity
In the current work, CEA and AFP were detected in two separated flow cells, so the cross-talk resulting from the diffusion of the reaction product was avoidable. According to the reported methods, 9 the cross reaction was tested between the antibodies and nonspecific antigens in the work. By incubating different concentrations of AFP antigens with AFP-Ab1/Fe3O4/SiO2 and HRP/AFP-Ab2/Au in the presence of 40 ng mL -1 CEA, we examined the effect of the co-existed CEA on the detection of AFP. The result showed that the variation of the CL intensities was 5.7%. According to the same method, the interference from the co-existing AFP was also carried out. The result showed that the variation of the CL intensities was 3.9%. Thus, the results indicated that the proposed strategy possessed an acceptable specificity and that the cross-reactivity could be negligible.
Clinical application and method comparison
In order to test the application value of this dual immunoassay system, we analyzed fifteen clinical serum samples by using the proposed method, and our results were compared with the results from the classical ELISA test performed in Qingdao Central Hospital (Shandong Province, China). The result shown in Table 2 indicates that the proposed strategy obtained an acceptable accuracy.
Conclusions
In this work, a sensitive dual immunoassay strategy was proposed for the sequential detection of tumor markers based on a signal amplification technique. Magnetic mesoporous silica, with large surface area and good magnetic separation, were synthesized to immobilize the monoclonal antibody. HRP labeled antibody and HRP were co-coated on AuNPs and used as the CL signal-amplified immunological probe. A parallel double-channel was set on the detection window for the simultaneous detection of CEA and AFP by controlling the CL substrate circulation through two switches. This method may provide a promising platform for simple, sensitive and low-cost determination for multiplexed immunoassay.
